Report overview
The automatic nucleic acid extractor is used in conjunction with supporting reagents for fully automatic extraction and purification of DNA/RNA, proteins and cells. The magnetic bead method is adopted to realize the transfer of magnetic beads/sample through the adsorption, transfer and release of magnetic beads by the magnetic rod and the magnetic rod sleeve, and complete the automatic extraction and purification operation. The operation is automated, fast and simple. Using a special kit or a 96-well reaction plate, 1 to 96 samples can be processed simultaneously. With different kinds of magnetic bead nucleic acid extraction reagents, it can be used for the extraction and purification of different nucleic acids in clinical samples.
This report contains market size and forecasts of Medical Automatic Nucleic Acid Extractor in global, including the following market information:
Global Medical Automatic Nucleic Acid Extractor Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Medical Automatic Nucleic Acid Extractor Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Medical Automatic Nucleic Acid Extractor companies in 2022 (%)
The global Medical Automatic Nucleic Acid Extractor market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Fully Automatic Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Medical Automatic Nucleic Acid Extractor include Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., Tecan Group AG., Sigma Aldrich Corp., Becton Dickinson and Company, QIAGEN, Bio-Rad Laboratories Inc. and PerkinElmer, Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Automatic Nucleic Acid Extractor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Automatic Nucleic Acid Extractor Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Medical Automatic Nucleic Acid Extractor Market Segment Percentages, by Type, 2022 (%)
Fully Automatic
Semi-automatic
Global Medical Automatic Nucleic Acid Extractor Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Medical Automatic Nucleic Acid Extractor Market Segment Percentages, by Application, 2022 (%)
Hospital
Nucleic Acid Diagnostic Institutions
Global Medical Automatic Nucleic Acid Extractor Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Medical Automatic Nucleic Acid Extractor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Automatic Nucleic Acid Extractor revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Automatic Nucleic Acid Extractor revenues share in global market, 2022 (%)
Key companies Medical Automatic Nucleic Acid Extractor sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Medical Automatic Nucleic Acid Extractor sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Agilent Technologies, Inc.
Tecan Group AG.
Sigma Aldrich Corp.
Becton Dickinson and Company
QIAGEN
Bio-Rad Laboratories Inc.
PerkinElmer, Inc.
F. Hoffmann-La Roche
DiaSorin S.p.A
SHINHUA
Esco Micro Pte. Ltd.
Analytik Jena GmbH
Aurora
